Loading...
Back to narrative

BRG: Government Support And Bio Project Will Support Stable Future Outlook

Analysts Adjust Borregaard Price Target and Valuation Following Recent Updates and Ongoing Developments

BRG logo
BRG
AnalystConsensusTarget
Not Invested
Published 02 Feb 2025

Update shared on 19 Dec 2025

Previous
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
10.0%
7D
1.0%

Analysts have marginally raised their price target on Borregaard to NOK 212.50, citing slightly lower discount rate assumptions while keeping revenue growth, profit margin, and future P E expectations essentially unchanged.

What's in the News

  • Norwegian Research Council awards Borregaard NOK 15 million for its Biomer innovation project, supporting development of bio based alternatives to fossil based polycarboxylates used in agriculture, industry, and household products (Norwegian Research Council)
  • Biomer project to leverage Borregaard’s Sarpsborg biorefinery and wood chemistry expertise to convert Norwegian bioresources into greener polymers with a significantly lower environmental footprint (Norwegian Research Council)

Valuation Changes

  • The fair value estimate remains unchanged at NOK 212.50 per share, indicating no revision to the overall intrinsic value assessment.
  • The discount rate has fallen slightly from 6.88 percent to 6.87 percent, reflecting a marginally lower assumed cost of capital.
  • The revenue growth assumption is essentially unchanged, holding at around 5.83 percent annually in the updated model.
  • The net profit margin forecast remains stable at approximately 12.70 percent, indicating no material change in expected profitability.
  • The future P/E multiple has edged down slightly from about 22.38x to 22.37x, suggesting a marginally lower valuation multiple applied to future earnings.

Have other thoughts on Borregaard?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.